Metabolic bariatric surgery is associated with a lower risk of major adverse cardiovascular events, as well as a lower risk of all-cause mortality, nephropathy, and retinopathy, when compared with ...

Metabolic surgery was associated with lower all-cause mortality and a lower risk for major adverse cardiac events than GLP-1 receptor agonists (RAs), based on data from a new study of more than 3000 ...

David Rometo, MD, weighs various weight loss treatments, their success, and sustainability. Bariatric surgery is more cost-effective and better at helping patients lose and maintain weight than ...

The MarketWatch News Department was not involved in the creation of this content. 40% of U.S. adults are now considered obese, leading to a dramatic surge in the utilization of the popular but pricey ...

Elena Losina, PhD, codirector of the Orthopedics and Arthritis Center for Outcomes Research at Brigham and Women’s Hospital, discusses the cost-effectiveness of varying weight loss interventions. The ...

New research shows that metabolic and bariatric surgery costs less than weekly injections of GLP-1 drugs over a two-year period. The corresponding study was presented at the annual scientific meeting ...

“We may not be as sexy anymore, but we’re cheaper.” The phrase, coined by Ricardo Cohen, president of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), was ...

More people are using glucagon-like peptide-1 (GLP-1) receptor agonist medications for weight loss, with fewer choosing to undergo metabolic bariatric surgery. New data published in JAMA Surgery show ...

Please provide your email address to receive an email when new articles are posted on . Tirzepatide and semaglutide may be cost-effective weight loss strategies for patients with knee osteoarthritis ...